Literature DB >> 12760884

Risk factors for fecal quinolone-resistant Escherichia coli in Mexican children.

Mussaret B Zaidi1, Emma Zamora, Pilar Diaz, Linda Tollefson, Paula J Fedorka-Cray, Marcia L Headrick.   

Abstract

We determined the prevalence of, and risk factors for, fecal quinolone-resistant Escherichia coli (QREC) in 324 children from Yucatan, Mexico. QREC was higher in children with recent Salmonella infection (100%) than in children with diarrhea (61%) or healthy children (54%) (P = 0.007). Multivariate analysis identified recent hospitalization of a family member (P = 0.011, odds ratio [OR] = 5.1) and carriage of Salmonella (P = 0.004, OR = 3.7) as independent risk factors for QREC.

Entities:  

Mesh：

Year:  2003        PMID： 12760884      PMCID： PMC155824          DOI： 10.1128/AAC.47.6.1999-2001.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.

Authors:  P Richard; M H Delangle; F Raffi; E Espaze; H Richet
Journal:  Clin Infect Dis       Date:  2000-12-11       Impact factor: 9.079

Review 2.  Spread of antibiotic resistance with food-borne pathogens.

Authors:  M Teuber
Journal:  Cell Mol Life Sci       Date:  1999-11-30       Impact factor: 9.261

3.  Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit.

Authors:  Mussaret Zaidi; José Sifuentes-Osornio; Ana Lilia Rolón; Gabriela Vázquez; Rilke Rosado; Mauro Sánchez; Juan J Calva; Samuel Ponce de León-Rosales
Journal:  Arch Med Res       Date:  2002 May-Jun       Impact factor: 2.235

4.  Antibiotic resistance--the interplay between antibiotic use in animals and human beings.

Authors:  Randall S Singer; Roger Finch; Henrik C Wegener; Robin Bywater; John Walters; Marc Lipsitch
Journal:  Lancet Infect Dis       Date:  2003-01       Impact factor: 25.071

5.  Emergence and dissemination of quinolone-resistant Escherichia coli in the community.

Authors:  J Garau; M Xercavins; M Rodríguez-Carballeira; J R Gómez-Vera; I Coll; D Vidal; T Llovet; A Ruíz-Bremón
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.

Authors:  S P Cohen; L M McMurry; D C Hooper; J S Wolfson; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 7.  Selective pressure by antibiotic use in livestock.

Authors:  W Witte
Journal:  Int J Antimicrob Agents       Date:  2000-11       Impact factor: 5.283

Review 8.  Epidemiology of resistance to antibiotics. Links between animals and humans.

Authors:  A E van den Bogaard; E E Stobberingh
Journal:  Int J Antimicrob Agents       Date:  2000-05       Impact factor: 5.283

9.  Trimethoprim-resistant Escherichia coli in households of children attending day care centers.

Authors:  M Fornasini; R R Reves; B E Murray; A L Morrow; L K Pickering
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

10.  Intrafamilial spreading of Escherichia coli resistant to trimethoprim.

Authors:  J Rydberg; A Cederberg
Journal:  Scand J Infect Dis       Date:  1986
View more
  9 in total

Review 1.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

2.  Comparative Analysis of Human and Animal E. coli: Serotyping, Antimicrobial Resistance, and Virulence Gene Profiling.

Authors:  Mahmoud M Bendary; Marwa I Abdel-Hamid; Walaa A Alshareef; Hanan M Alshareef; Rasha A Mosbah; Nasreen N Omar; Mohammad M Al-Sanea; Majid Alhomrani; Abdulhakeem S Alamri; Walaa H Moustafa
Journal:  Antibiotics (Basel)       Date:  2022-04-21

3.  Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.

Authors:  Ebbing Lautenbach; Joshua P Metlay; Mark G Weiner; Warren B Bilker; Pam Tolomeo; Xiangqun Mao; Irving Nachamkin; Neil O Fishman
Journal:  Infect Control Hosp Epidemiol       Date:  2009-01       Impact factor: 3.254

4.  Risk factors for antibiotic-resistant E. coli in children in a rural area.

Authors:  J C Seidman; P Anitha K; R Kanungo; A L Bourgeois; C L Coles
Journal:  Epidemiol Infect       Date:  2008-11-12       Impact factor: 2.451

5.  Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil.

Authors:  Isabel C A Scaletsky; Tamara B Souza; Katia R S Aranda; Iruka N Okeke
Journal:  BMC Microbiol       Date:  2010-01-27       Impact factor: 3.605

6.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

7.  Presence of multi-drug resistant pathogenic Escherichia coli in the San Pedro River located in the State of Aguascalientes, Mexico.

Authors:  Flor Y Ramírez Castillo; Francisco J Avelar González; Philippe Garneau; Francisco Márquez Díaz; Alma L Guerrero Barrera; Josée Harel
Journal:  Front Microbiol       Date:  2013-06-17       Impact factor: 5.640

Review 8.  Faecal carriage of antibiotic resistant Escherichia coli in asymptomatic children and associations with primary care antibiotic prescribing: a systematic review and meta-analysis.

Authors:  Ashley Bryce; Céire Costelloe; Claire Hawcroft; Mandy Wootton; Alastair D Hay
Journal:  BMC Infect Dis       Date:  2016-07-25       Impact factor: 3.090

9.  Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan.

Authors:  I-Fei Huang; Wei-Yang Lee; Jiun-Ling Wang; Chih-Hsin Hung; Hong-Hsiang Hu; Wan-Yu Hung; Yun-Ju Hung; Wen-Chi Chen; Ying-Tso Shen; Ming-Fang Cheng
Journal:  BMC Gastroenterol       Date:  2018-06-15       Impact factor: 3.067
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.